Sachin Kulkarni took a good look at his life when he turned 40 and decided to get a checkup. After that, everything changed ...

For the past year, Kulkarni had noticed some gastrointestinal issues, but he suspected it was nothing more than irritable bowel syndrome, or IBS. A visit to his primary care physician found that his ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug ...

SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

Rates of colorectal cancer are increasing among young people—and most Americans are only getting about half their daily ...

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

A team of US-based researchers has concluded that high-dose vitamin D3 does not provide any additional benefit for patients ...

Study Title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate predictions when compared with ...

A potential benefit for high-dose vitamin D3 was observed for patients with left-sided disease (i.e., primary tumors that ...

A team of US researchers on Sunday said that high-dose vitamin D3 does not provide benefit for patients suffering from metastatic colorectal cancer. A randomised phase 3 clinical trial led by ...